Population Assessment of Tobacco and Health (PATH) Study [United States] Master Linkage Files

The PATH Study was launched in 2011 to inform the Food and Drug Administration's regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study sampled over 150,000 mailing addresses across the United States to create a national sample of those who do and do not use tobacco. 45,971 adults and youth constitute the first (baseline) wave, Wave 1, of data collected by this longitudinal cohort study. These 45,971 adults and youth along with 7,207 "shadow youth" (youth ages 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete the Youth Interview after parental consent. At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled Primary Sampling Units (PSUs) and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort. At Wave 7, a probability sample of 14,863 adults, youth, and shadow youth ages 9 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 7. This sample was recruited from residential addresses not selected for Wave 1 or Wave 4 in the same sampled PSUs and segments using similar within-household sampling procedures. This second replenishment sample was combined for estimation and analysis purposes with Wave 7 adult and youth respondents from the Wave 4 Cohort who were at least age 15 and in the civilian, noninstitutionalized population at the time of Wave 7. This combined set of Wave 7 participants, 46,169 participants in total, forms the Wave 7 Cohort. Please refer to the Restricted-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1, Wave 4, and Wave 7 Cohorts. Dataset 0001 (DS0001) contains the data from the Public-Use File Master Linkage File (PUF-MLF). This file contains 77 variables and 67,276 cases. The file provides a master list of every person's unique identification number and what type of respondent they were in each wave for data that are available in the Public-Use Files and Special Collection Public-Use Files. Dataset 0002 (DS0002) contains the data from the Restricted-Use File Master Linkage File (RUF-MLF). This file contains 179 variables and 82,139 cases. The file provides a master list of every person's unique identification number and what type of respondent they were in each wave for data that are available in the Restricted-Use Files, Special Collection Restricted-Use Files, and Biomarker Restricted-Use Files.

PATH研究于2011年启动，旨在为食品药品监督管理局（FDA）根据《家庭吸烟预防与烟草控制法案》（TCA）实施监管活动提供信息。PATH研究是由国家药物滥用研究所（NIDA）、国家卫生研究院（NIH）和食品药品监督管理局（FDA）下属的烟草产品中心（CTP）共同协作进行的。该研究对美国超过15万个邮寄地址进行了抽样，以构建一个全国范围内的烟草使用者与非使用者的样本库。构成该纵向队列研究首次（基线）数据收集的，共有45,971名成人和青少年。这45,971名成人和青少年以及7,207名“影子青少年”（在第一波中抽取的9至11岁青少年）共同构成了53,178名参与者的第一波队列。受访者在每个后续波次中均需完成一次访谈。至当前数据收集波次时年满18岁的青少年被视为“成年青少年”，并被邀请完成成人访谈。此外，“影子青少年”在年满12岁时，在获得家长同意后，需完成青少年访谈。在第四波次中，从第四波次的平民、非机构化人群中选取了14,098名成人、青少年和10至11岁的“影子青少年”作为概率样本。该样本来自未在第一波次中选中的同一样本主要抽样单位（PSU）和分段中的住宅地址，并采用类似的户内抽样程序进行招募。这一“补充样本”与第四波次来自第一波次队列的平民、非机构化成人及青少年受访者相结合，用于估计和分析，总共形成了52,731名参与者的第四波次队列。在第七波次中，从第七波次的平民、非机构化人群中选取了14,863名成人、青少年和9至11岁的“影子青少年”作为概率样本。该样本来自未在第一波次或第四波次中选中的同一样本PSU和分段中的住宅地址，并采用类似的户内抽样程序进行招募。这一第二个补充样本与第七波次来自第四波次队列的至少15岁且为平民、非机构化人群的成人及青少年受访者相结合，用于估计和分析，总共形成了46,169名参与者的第七波次队列。请参阅关于指定为“影子青少年”的儿童以及第一波次、第四波次和第七波次队列形成的《受限使用文件用户指南》，以获取更多详细信息。数据集0001（DS0001）包含来自公共使用文件主链接文件（PUF-MLF）的数据。该文件包含77个变量和67,276个案例。该文件提供了每个个人的唯一识别号码以及在每个波次中他们的受访者类型的主列表，这些数据可在公共使用文件和特别收集公共使用文件中找到。数据集0002（DS0002）包含来自受限使用文件主链接文件（RUF-MLF）的数据。该文件包含179个变量和82,139个案例。该文件提供了每个个人的唯一识别号码以及在每个波次中他们的受访者类型的主列表，这些数据可在受限使用文件、特别收集受限使用文件和生物标志物受限使用文件中找到。